Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07034677 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Treatment With Indapamide in Patients With Post-Surgical Hypoparathyroidism

Study acronym: HYPOCARE treat
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 11, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jun 2025 to Aug 2025
    • Secondary endpoints revised (3)
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to investigate the effect of daily treatment with Indapamide for 14 days on urinary calcium excretion in patients with post surgical hypoparathyroidisme.
Trial Details
NCT Number NCT07034677
Lead Sponsor Lars Rejnmark
Conditions
(from sponsor)		 Hypoparathyroidism Post-surgical
Related terms Hypercalciuria, Hypoparathyroidism
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov